Parallax Volatility Advisers, L.P. Arcutis Biotherapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $66,906 - $138,348	12,600 Added 340.54%	16,300 $86,000
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $1.14 Million - $2.28 Million	-152,100 Reduced 97.63%	3,700 $35,000
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $542,190 - $908,420	53,000 Added 51.56%	155,800 $1.71 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $1.44 Million - $2.1 Million	102,800 New	102,800 $1.52 Million

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $631M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.